Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy responseYan Mei, Guangshuai Jia, Xiumei Wang et al.|Nature Cancer|2023Cited by 219
Increased serum interleukin 17 in patients with systemic lupus erythematosusXuefei Zhao, Dong‐Qing Ye, Xiang-Pei Li et al.|Molecular Biology Reports|2009Cited by 135